New TAAT ™ facilities now operational, tobacco wholesalers

LAS VEGAS and VANCOUVER, British Columbia, September 03, 2021 (GLOBE NEWSWIRE) – TAAT GLOBAL ALTERNATIVES INC. (CSE: TAAT), (OTCQX: TOBAF), (FRANKFURT: 2TP), (the “Company” or “TAAT”) is pleased to announce that it has begun operating from its new facility in the Las Vegas, Nevada area, providing significant additional operational space and production resources in combination with its original facility on West Post Road. In a dated press release July 16, 2021, the Company announced that its tasks of preparing the new facilities were still on schedule for a launch the following month, in line with the Company’s business objectives for domestic and international activities already underway. Since then, TAAT ™ has announced new purchase orders for distribution in the UK, Ireland and Australia totaling over CA $ 1,600,000 (in press releases dated August 20, 2021 and August 27, 2021), in addition to the distribution of TAAT ™ in seven new US states in just two months (in a August 17, 2021 Press release). Also in its third full calendar quarter of retail availability, global demand for TAAT ™ grew steadily through 2021 as the company diligently coordinated strategic launches across a wide range of markets.

A photo accompanying this announcement is available at

Readers using news aggregation services may not be able to view the above media. Please access SEDAR or Investor Relations section of the Company’s website for a version of this press release containing all published media.

A photo accompanying this announcement is available at

Readers using news aggregation services may not be able to view the above media. Please access SEDAR or Investor Relations section of the Company’s website for a version of this press release containing all published media.

In addition, samples of TAAT ™ with an advanced formulation of Beyond Tobacco ™ using reconstituted material were recently sent to tobacco wholesalers in USA, UK, Ireland, Germany, Poland, France. and in Switzerland. The general consensus among tobacco wholesalers who received these samples was overwhelmingly positive regarding the similarity of the user experience of the product to that of a tobacco cigarette. Based on anecdotal comments from smokers aged 21 and over and TAAT ™ retailers, as well as survey responses from consumer studies conducted earlier this year (detailed in the Company’s report April 14, 2021 press release), the Company has identified several opportunities to improve the TAAT ™ user experience using material reconstructed in Beyond Tobacco ™. The advanced formulation has been developed with the aim of making improvements to include the following:

  • Combinations of flavors to generate a taste and odor more like real tobacco;
  • Higher production speed, thereby increasing the overall efficiency of the Company’s manufacturing processes in its new facilities;
  • Significantly less weight of each TAAT ™ stick, approximately corresponding to the weight of a typical tobacco cigarette;
  • Burn rate adjusted to ensure smokers aged 21 and over who use TAAT ™ will end up each stick with approximately the same “number of puffs” as a standard tobacco cigarette of the same length; and
  • Cut the base material differently to ensure that each TAAT ™ stick burns evenly to the end without prematurely extinguishing.

The reconstituted formulation of Beyond Tobacco ™ is now ready for production, which is expected to begin this quarter.

TAAT ™ CEO Setti Coscarella said: “With so many new international opportunities on the horizon, expanding our facilities is a very important part of our growth strategy as we enter our second year of business. operation during which we anticipate the launch of TAAT ™. in several new markets. With an abundance of feedback on TAAT ™ from smokers aged 21 and over who have tested the product since its launch in Ohio in Q4 2020, our advanced formulation of the Beyond Tobacco ™ base material has made the user experience even closer to that of smoking a tobacco cigarette. Samples of TAAT ™ with this advanced formulation have been sent to tobacco wholesalers across Europe, and based on their sentiments, we are very confident that there will be even more TAAT ™ placements in European markets. in the near future.

On behalf of the Board of Directors of the Company,


“Setti Coscarella”

Setti Coscarella, CEO and Director

For more information, please contact:

TAAT ™ Investor Relations
1-833-TAAT-United States (1-833-822-8872)
[email protected]


About TAAT Global Alternatives Inc.

The Company has developed TAAT ™, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in the “Original”, “Smooth” and “Menthol” varieties. The base material of TAAT ™ is Beyond Tobacco ™, a proprietary blend that undergoes a patent pending refinement technique that makes its scent and taste resemble tobacco. Under the leadership of management with the “Big Tobacco” pedigree, TAAT ™ was first launched in the United States in the fourth quarter of 2020 as the company seeks to position itself in the $ 814 billion mark.1 the global tobacco industry.

For more information, please visit

The references

1 British American Tobacco – The Global Market

Forward-looking statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “believes” , “Intention”, “” anticipates “or” does not anticipate “, or” believes “, or variations of these words and expressions or states that certain actions, events or results” could “,” could “,” would “,” could “or” would “be taken, occur or be attained. Forward-looking information contained in this press release includes statements regarding the anticipated performance of TAAT ™ in the tobacco industry, in addition to the following : Potential results of the operations of the new TAAT ™ facilities in Las Vegas, potential performances and reception of The Beyond Tobacco ™ formulation, potential results related to the first returns of tobacco wholesalers in Europe who recently received samples of TAAT ™ with the formula advanced Beyond Tobacco ™. Forward-looking information reflects management’s current expectations based on information currently available and is subject to a number of risks and uncertainties that may cause results to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in the preparation of forward-looking information are reasonable, such information should not be relied on unduly and no guarantee can be given that such events will occur within the time limits disclosed or in the future. all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes in the growth and size of tobacco markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly changing environment. New risk factors emerge from time to time, and it is impossible for the management of the Company to predict all risk factors, nor can the Company assess the impact of all factors on the business of the Company. Company or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. , unless required by applicable law.

The statements contained in this press release have not been evaluated by Health Canada or the United States Food and Drug Administration. Because everyone is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claim or guarantee can be made as to the effects of the Company’s products on the health and well-being of an individual. The Company’s products are not intended to diagnose, treat, cure or prevent any disease.

This press release may contain brand names of third party entities (or their respective offerings with brand names) generally in reference (i) to the relationship between the Company and the third party entities mentioned in this release and / or (ii) the client / supplier / service provider parties whose relationship with the Company is / are mentioned in this press release. All rights to these trademarks are reserved by their respective owners or licensees.

Statement Regarding Third Party Investor Relations Firms

Information relating to investor relations firms retained by TAAT ™ Global Alternatives Inc. can be viewed under the Company’s profile on

Source link

About Margaret Shaw

Check Also

House Democrats seek to raise taxes on vapers as smokers continue to die

On September 12, influential House Democrats circulate a new tax proposal around Washington aimed to …

Leave a Reply

Your email address will not be published. Required fields are marked *